DBV Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DBVT and buy or sell other stocks, ETFs, and their options commission-free!About DBVT
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients.
CEODaniel Tassé
CEODaniel Tassé
Employees109
Employees109
HeadquartersChatillon, Hauts-de-France
HeadquartersChatillon, Hauts-de-France
Founded2002
Founded2002
Employees109
Employees109
DBVT Key Statistics
Market cap1.27B
Market cap1.27B
Price-Earnings ratio-4.35
Price-Earnings ratio-4.35
Dividend yield—
Dividend yield—
Average volume164.30K
Average volume164.30K
High today$23.08
High today$23.08
Low today$22.73
Low today$22.73
Open price$21.96
Open price$21.96
Volume8.98K
Volume8.98K
52 Week high$26.19
52 Week high$26.19
52 Week low$3.91
52 Week low$3.91
DBVT News
TipRanks 4d
DBV Technologies announces Phase 3 Vitesse trial met primary endpointDBV Technologies (DBVT) announced that the company shared additional positive data from the successful Phase 3 Vitesse clinical trial as an oral presentation at...
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
0%
Sell
11.1%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.